
Keywords: X-ray crystallography; Fragment screening; HIV; Influenza; BpGCDH; B. pseudomallei glutaryl-CoA dehydrogenase; DHNA; 7,8-dihydroneopterin aldolase; DMSO; dimethylsulfoxide; FBDD; fragment-based drug discovery; HCV; hepatitis C virus; HIV; human immunodef